These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9830950)

  • 21. Mutations in MODY genes are not common cause of early-onset type 2 diabetes in Mexican families.
    Domínguez-López A; Miliar-García A; Segura-Kato YX; Riba L; Esparza-López R; Ramírez-Jiménez S; Rodríguez-Torres M; Canizales-Quinteros S; Cabrera-Vásquez S; Fragoso-Ontiveros V; Aguilar-Salinas CA; Altamirano-Bustamante N; Calzada-León R; Robles-Valdés C; Bravo-Ríos LE; Tusié-Luna MT
    JOP; 2005 May; 6(3):238-45. PubMed ID: 15883474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [From gene to disease; 'maturity-onset diabetes of the young' (MODY), monogenetic inheritable forms of diabetes mellitus].
    Maassen JA; Lemkes HH; Losekoot M
    Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1352-3. PubMed ID: 11484433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of HNF1A and GCK mutations in Canadian families with maturity-onset diabetes of the young (MODY).
    McKinney JL; Cao H; Robinson JF; Metzger DL; Cummings E; Riddell DC; Sanderson SR; Pacaud D; Ho J; Hegele RA
    Clin Invest Med; 2004 Jun; 27(3):135-41. PubMed ID: 15305805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects.
    Ferrannini E
    Endocr Rev; 1998 Aug; 19(4):477-90. PubMed ID: 9715376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes mellitus among children and adolescents in Al-Ain: a case series.
    Punnose J; Agarwal MM; Bin-Uthman S
    East Mediterr Health J; 2005 Jul; 11(4):788-97. PubMed ID: 16700395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.
    Hani EH; Stoffers DA; Chèvre JC; Durand E; Stanojevic V; Dina C; Habener JF; Froguel P
    J Clin Invest; 1999 Nov; 104(9):R41-8. PubMed ID: 10545531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity-onset diabetes of the young? The case of autoimmunity-associated destruction of pancreatic β-cells in a family of HNF1A-MODY subjects.
    Urbanová J; Rypáčková B; Kučera P; Anděl M; Heneberg P
    Int Arch Allergy Immunol; 2013; 161(3):279-84. PubMed ID: 23548576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The therapeutic approach to the obese maturity-onset diabetic patient.
    Lipson LG; Lipson M
    Arch Intern Med; 1984 Jan; 144(1):135-8. PubMed ID: 6362593
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic and clinical characteristics of maturity-onset diabetes of the young.
    Giuffrida FM; Reis AF
    Diabetes Obes Metab; 2005 Jul; 7(4):318-26. PubMed ID: 15955117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [MODY type diabetes: overview and recent findings].
    Ben Khelifa S; Barboura I; Dandana A; Ferchichi S; Miled A
    Ann Biol Clin (Paris); 2011; 69(5):531-40. PubMed ID: 22008132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?
    Kim SH
    Diabetes Metab J; 2015 Dec; 39(6):468-77. PubMed ID: 26706916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization.
    Owen K; Hattersley AT
    Best Pract Res Clin Endocrinol Metab; 2001 Sep; 15(3):309-23. PubMed ID: 11554773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents.
    Goran MI; Ball GD; Cruz ML
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1417-27. PubMed ID: 12679416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance in maturity onset diabetes of the young.
    Mohan V; Sharp PS; Aber VR; Mather HM; Kohner EM
    Diabete Metab; 1987 Jun; 13(3):193-7. PubMed ID: 3301443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetics of type 2 diabetes mellitus: genes implicated in early onset diabetes].
    Tusié Luna MT
    Rev Invest Clin; 2000; 52(3):296-305. PubMed ID: 10953613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers: Tools for Discriminating MODY from Other Diabetic Subtypes.
    Firdous P; Nissar K; Masoodi SR; Ganai BA
    Indian J Endocrinol Metab; 2022; 26(3):223-231. PubMed ID: 36248040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional study of the GlnB22-insulin mutant responsible for maturity-onset diabetes of the young.
    Křížková K; Veverka V; Maletínská L; Hexnerová R; Brzozowski AM; Jiráček J; Žáková L
    PLoS One; 2014; 9(11):e112883. PubMed ID: 25423173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity, insulin resistance, and type 2 diabetes in children and adolescents.
    Rappaport EB; Usher DC
    Pediatr Ann; 2006 Nov; 35(11):822-6. PubMed ID: 17153129
    [No Abstract]   [Full Text] [Related]  

  • 40. Early onset type 2 diabetes mellitus: an update.
    Strati M; Moustaki M; Psaltopoulou T; Vryonidou A; Paschou SA
    Endocrine; 2024 Sep; 85(3):965-978. PubMed ID: 38472622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.